Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Recent studies have indicated the existence of tumorigenesis barriers that slow or inhibit the progression of preneoplastic lesions to neoplasia. One such barrier involves DNA replication stress, which leads to activation of the DNA damage checkpoint and thereby to apoptosis or cell cycle arrest, whereas a second barrier is mediated by oncogene-induced senescence. The relationship between these two barriers, if any, has not been elucidated. Here we show that oncogene-induced senescence is associated with signs of DNA replication stress, including prematurely terminated DNA replication forks and DNA double-strand breaks. Inhibiting the DNA double-strand break response kinase ataxia telangiectasia mutated (ATM) suppressed the induction of senescence and in a mouse model led to increased tumour size and invasiveness. Analysis of human precancerous lesions further indicated that DNA damage and senescence markers cosegregate closely. Thus, senescence in human preneoplastic lesions is a manifestation of oncogene-induced DNA replication stress and, together with apoptosis, provides a barrier to malignant progression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Oncogene activation is a powerful inducer of cellular senescence. Oncogene expression triggers an initial hyperproliferative phase that is intrinsically associated with altered DNA replication, which eventually engages DDR pathways and causes senescence7,8,39”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [8]
In the citing paper
“It has been shown that one mechanism for the link between the initial mitotic reaction and senescence induction is the S-phase-associated DDR: The oncogenic stress drives increased DNA replication origins, leading to accumulation of incomplete replication intermediates, resulting in DNA damage and activation of the DDR kinases (ATM, ATR, CHK2, and CHK1) (Bartkova et al. 2006; Di Micco et al. 2006;”
From Cellular senescence and its effector programs (2014) · cites this paper as Bartkova et al. 2006
In the citing paper
“Colon adenomas, which are stable precursor lesions of invasive colon cancer, were found to be negative for the proliferation marker Ki67 and positive for SA- β- gal 87,88 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [87]
In the citing paper
“colon adenoma- derived samples also have elevated expression of p16 INK4a , HP1γ (an H3K9me3- enriched senescence- associated heterochromatin focus- promoting scaffold that connects H3K9 methyltransferases to Rb as another binding partner), and focal γH2AX expression, indicating enhanced DNA damage 87,89 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [87]
In the citing paper
“In particular, E1A inhibits p53 phosphorylation at serine 15 (14), a hallmark of the activation of the DNA damage response during senescence (3, 12).”
From Mitochondrial Dysfunction Contributes to Oncogene-Induced Senescence (2009) · cites this paper as [3]
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
A System for Stable Expression of Short Interfering RNAs in Mammalian Cells
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Science · doi:10.1126/science.1068999 · Cited by 4,291
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Self-citationRb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Self-citationCrucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., et al. (2006) · Nature · doi:10.1038/nature05327 · Cited by 1,821
Senescence in premalignant tumours
Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482
Cited by
Items 401–500 of 1,016
Katlinskaya, Y. V., Katlinski, K. V., Yu, Q., Ortiz, A., Beiting, D. P., Brice, A., Davar, D., Sanders, C., Kirkwood, J. M., Rui, H., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.03.006 · Cited by 108
“Activation of DNA damage responses plays a central role in the development of OIS (Bartkova et al., 2006; Di Micco et al., 2006).”
BackgroundIntegrating the DNA damage and protein stress responses during cancer development and treatment
Gorgoulis, V. G., Pefani, D., Pateras, I. S., & Trougakos, I. P. (2018) · The Journal of Pathology · doi:10.1002/path.5097 · Cited by 108
“In accordance with the main prediction of our model, p53 function was gradually attenuated, apoptosis was reduced, and a fraction of senescent cells escaped, showing aggressive traits [Figure 5(4–6); lower panel] [159,314,327,342], such as increased invasiveness, aneuploidy,* and features reminiscent of EMT* [159,314,…”
BackgroundResultSelf-citationTo clear, or not to clear (senescent cells)? That is the question
Lujambio, A. (2016) · BioEssays · doi:10.1002/bies.201670910 · Cited by 108
New insights into the role of PML in tumour suppression
Salomoni, P., Ferguson, B. J., Wyllie, A. H., & Rich, T. (2008) · Cell Research · doi:10.1038/cr.2008.58 · Cited by 125
“considered to be one of the main barriers against tumourigenesis, and there is good evidence that it is caused by induction of the DNA damage response [109-111].”
BackgroundEndogenous DNA replication stress results in expansion of dNTP pools and a mutator phenotype
Davidson, M. B., Katou, Y., Keszthelyi, A., Sing, T. L., Xia, T., Ou, J., Vaisica, J. A., Thevakumaran, N., Marjavaara, L., Myers, C. L., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.485 · Cited by 127
“…to note recent observations that pre-cancerous lesions show evidence of DNA damage response activation (Bartkova et al , 2005; Gorgoulis et al , 2005) and that this activation can result from oncogene expression and the resulting replication stress (Bartkova et al , 2006; Di Micco et al , 2006).”
Han, C., Liu, Y., Wan, G., Choi, H. J., Zhao, L., Ivan, C., He, X., Sood, A. K., Zhang, X., & Lu, X. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.058 · Cited by 104
“However, tumor progression is often accompanied by inactivation of DNA damage response and p53 (Bartkova et al., 2006; Halazonetis et al., 2008).”
BackgroundSOCS1 regulates senescence and ferroptosis by modulating the expression of p53 target genes
Saint-Germain, E., Mignacca, L., Vernier, M., Bobbala, D., Ilangumaran, S., & Ferbeyre, G. (2017) · Aging · doi:10.18632/aging.101306 · Cited by 102
“OIS is triggered by activated oncogenes and involves replication stress, mitochondrial dysfunction, reactive oxygen species and the DNA damage response [30,31,32].”
BackgroundBiological functions of therapy-induced senescence in cancer
Fitsiou, E., Soto-Gamez, A., & Demaria, M. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.03.021 · Cited by 111
Bonagas, N., Gustafsson, N., Henriksson, M., Marttila, P., Gustafsson, R., Wiita, E., Borhade, S. R., Green, A. C., Vallin, K. S. A., Sarno, A., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00331-y · Cited by 114
“revealed that: (1) the diaminopyrimidine head group did not tolerate any structural modifications, (2) the urea linker and central phenyl ring displayed highly specific SARs and (3) the glutamate tail could be replaced by a variety of amino acids and isosteres.”
BackgroundSelf-citationZheng, L., Dai, H., Zhou, M., Li, X., Liu, C., Guo, Z., Wu, X., Wu, J., Wang, C., Zhong, J., et al. (2012) · Nature Communications · doi:10.1038/ncomms1825 · Cited by 99
“These molecular mechanisms have been thought to prevent early tumor progression 11, 12, 41 .”
Thaler, S., Hähnel, P. S., Schad, A., Dammann, R., & Schüler, M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1377 · Cited by 113
Prevention of DNA re-replication in eukaryotic cells
Truong, L. N., & Wu, X. (2011) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjq052 · Cited by 119
“…E, and Cdc25A, induce unscheduled DNA replication or DNA re-replication at pre-cancerous stages of tumorigenesis, generating signals to activate DNA damage checkpoint response, and subsequent loss of checkpoint barriers leads to tumorigenesis (Bartkova et al., 2005, 2006; Di Micco et al., 2006).”
BackgroundCellular features of senescence during the evolution of human and murine ductal pancreatic cancer
Caldwell, M. E., DeNicola, G. M., Martins, C. P., Jacobetz, M. A., Maitra, A., Hruban, R. H., & Tuveson, D. A. (2012) · Oncogene · doi:10.1038/onc.2011.350 · Cited by 97
“OIS arrested cells have been identified in the non-invasive precursor stages of cancer development (Braig et al., 2005; Collado et al., 2005; Michaloglou et al., 2005; Bartkova et al., 2006; Courtois-Cox et al., 2006; Di Micco et al., 2006; Dankort et al., 2007; Sun et al., 2007; Halazonetis et al., 2008; Majumder et…”
Scarless wound healing: From development to senescence
Pratsinis, H., Mavrogonatou, E., & Kletsas, D. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.04.011 · Cited by 103
Self-citationRegulation of senescence and the SASP by the transcription factor C/EBPβ
Salotti, J., & Johnson, P. F. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110752 · Cited by 103
A potent Chk1 inhibitor is selectively cytotoxic in melanomas with high levels of replicative stress
Brooks, K. M., Oakes, V., Edwards, B., Ranall, M. V., Leo, P., Pavey, S. J., Pinder, A., Beamish, H., Mukhopadhyay, P., Lambie, D., et al. (2012) · Oncogene · doi:10.1038/onc.2012.72 · Cited by 107
PIF1 helicase promotes break‐induced replication in mammalian cells
Li, S., Wang, H., Jehi, S. E., Li, J., Liu, S., Wang, Z., Truong, L. N., Chiba, T., Wang, Z., & Wu, X. (2021) · The EMBO Journal · doi:10.15252/embj.2020104509 · Cited by 108
“Oncogene expression often results in replication stress, leading to fork collapse and DSB formation (Bartkova et al , 2006; Di Micco et al , 2006), which is one driving force behind genome instability.”
Sigl, R., Wandke, C., Rauch, V., Kirk, J. A., Hunt, T. D., & Geley, S. (2009) · Journal of Cell Science · doi:10.1242/jcs.054197 · Cited by 116
“Shortening of G1 phase and forced entry into S phase might limit the number of functional pre-RCs or might lead to replication fork collapse, as suggested previously (Bartkova et al., 2006; Di Micco et al., 2006).”
ResultGenome amplification and cellular senescence are hallmarks of human placenta development
Velicky, P., Meinhardt, G., Plessl, K., Vondra, S., Weiss, T., Haslinger, P., Lendl, T., Aumayr, K., Mairhofer, M., Zhu, X., et al. (2018) · PLOS Genetics · doi:10.1371/journal.pgen.1007698 · Cited by 102
Targeting DNA Replication Stress for Cancer Therapy
Zhang, J., Dai, Q., Park, D., & Deng, X. (2016) · Genes · doi:10.3390/genes7080051 · Cited by 102
“It is postulated that oncogene activation can stimulate the G1-S cell cycle transition, resulting in premature onset of S phase and therefore insufficient levels of DNA replicative enzymes and/or nucleotides, which are prerequisites for accurate DNA replication [5,6].”
BackgroundChiba, N., Comaills, V., Shiotani, B., Takahashi, F., Shimada, T., Tajima, K., Winokur, D., Hayashida, T., Willers, H., Brachtel, E. F., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018867108 · Cited by 111
“In addition to DSBs, the oncogenic stress induced by various oncogenes activates ATM (9).”
BackgroundCdc6 expression represses E-cadherin transcription and activates adjacent replication origins
Sideridou, M., Zakopoulou, R., Evangelou, K., Liontos, M., Kotsinas, A., Rampakakis, E., Gagos, S., Kahata, K., Grabusic, K., Gkouskou, K., et al. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201108121 · Cited by 98
Self-citationZhan, H., Suzuki, T., Aizawa, K., Miyagawa, K., & Nagai, R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.125138 · Cited by 96
Cellular senescence and tumor promotion: Is aging the key?
Loaiza, N., & Demaria, M. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.01.007 · Cited by 101
Initiation of Genome Instability and Preneoplastic Processes through Loss of Fhit Expression
Saldivar, J. C., Miuma, S., Bene, J., Hosseini, S. A., Shibata, H., Sun, J., Wheeler, L. J., Mathews, C. K., & Huebner, K. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003077 · Cited by 112
“checkpoints and causes cellular senescence, forming a barrier to cancer progression [7,8].”
BackgroundThe stress kinase MKK7 couples oncogenic stress to p53 stability and tumor suppression
Schramek, D., Kotsinas, A., Meixner, A., Wada, T., Elling, U., Pospisilik, J. A., Neely, G. G., Zwick, R. H., Sigl, V., Forni, G., et al. (2011) · Nature Genetics · doi:10.1038/ng.767 · Cited by 115
“As Ras promotes oncogene-induced senescence (OIS) by activating CHK2 in vitro and in vivo”
Self-citationConnecting autophagy to senescence in pathophysiology
Young, A. R. J., & Narita, M. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.12.005 · Cited by 107
Hubáčková, S., Kucerova, A., Michlits, G., Kyjacová, L., Reiniš, M., Korolov, O., Bártek, J., & Hodný, Z. (2015) · Oncogene · doi:10.1038/onc.2015.162 · Cited by 106
Polymerase δ replicates both strands after homologous recombination–dependent fork restart
Miyabe, I., Mizuno, K., Keszthelyi, A., Daigaku, Y., Skouteri, M., Mohebi, S., Kunkel, T. A., Murray, J. M., & Carr, A. M. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3100 · Cited by 110
“Such oncogene-induced stress provides a barrier to carcinogenesis through the activation of the DNA structure checkpoints 48 .”
Self-inflicted DNA double-strand breaks sustain tumorigenicity and stemness of cancer cells
Liu, X., Li, F., Huang, Q., Zhang, Z., Zhou, L., Deng, Y., Zhou, M., Fleenor, D. E., He, W., Kastan, M. B., et al. (2017) · Cell Research · doi:10.1038/cr.2017.41 · Cited by 104
DNA replication stress: oncogenes in the spotlight
Primo, L. M. F., & Teixeira, L. K. (2020) · Genetics and Molecular Biology · doi:10.1590/1678-4685gmb-2019-0138 · Cited by 102
Liu, B., Peng, Z., Zhang, H., Zhang, N., Liu, Z., Xia, Z., Huang, S., Luo, P., & Cheng, Q. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02284-z · Cited by 105
Evangelou, K., Veroutis, D., Paschalaki, K., Foukas, P. G., Lagopati, N., Dimitriou, M., Papaspyropoulos, A., Konda, B., Hazapis, O., Polyzou, A., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.02951-2021 · Cited by 98
Self-citationHorikawa, I., Fujita, K., Jenkins, L. M. M., Hiyoshi, Y., Mondal, A. M., Vojtesek, B., Lane, D. P., Appella, E., & Harris, C. C. (2014) · Nature Communications · doi:10.1038/ncomms5706 · Cited by 92
Replication Stress Shapes a Protective Chromatin Environment across Fragile Genomic Regions
Kim, J., Sturgill, D. M., Sebastian, R., Khurana, S., Tran, A. D., Edwards, G. B., Kruswick, A., Burkett, S. S., Hosogane, E. K., Hannon, W. W., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.11.021 · Cited by 103
“Moreover, RS was found to promote aberrant DDR signaling, which can trigger irreversible cell-cycle arrest in primary cells (Bartkova et al., 2006; Di Micco et al., 2006).”
InfluentialZampetidis, C. P., Galanos, P., Angelopoulou, A., Zhu, Y., Polyzou, A., Karamitros, T., Kotsinas, A., Lagopati, N., Mourkioti, I., Mirzazadeh, R., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.10.017 · Cited by 87
Self-citationFacilitating replication under stress: an oncogenic function of MYC?
Herold, S., Herkert, B., & Eilers, M. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2640 · Cited by 104
“Importantly, several recent observations show that oncogene-induced senescence depends on checkpoint signalling and that active checkpoint signals are sufficient to trigger senescence even in the absence of DNA damag”
NADPH oxidases: new actors in thyroid cancer?
Hassani, R. A. E., Schlumberger, M. J., & Dupuy, C. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.64 · Cited by 99
The Vitamin D Receptor as Tumor Suppressor in Skin
Bikle, D. D. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-46227-7_14 · Cited by 98
Genetics of melanoma progression: the rise and fall of cell senescence
Bennett, D. C. (2016) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12422 · Cited by 85
“Telomeres have a protective protein cap, the shelterin complex (Martínez and Blasco, 2011), but when a telomere reaches a critically short length, its cap is destabilized and the DNA end becomes exposed, leading to mis‐recognition of this end as a DNA double‐strand break (Bartkova et al., 2006; Rossiello et al., 2014;…”
BackgroundThe role of senescence in cancer development
Mavrogonatou, E., Pratsinis, H., & Kletsas, D. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.06.018 · Cited by 106
Self-citationTranscriptional regulation of cellular senescence
Lanigan, F., Geraghty, J. G., & Bracken, A. P. (2011) · Oncogene · doi:10.1038/onc.2011.34 · Cited by 95
“…mechanism that acts to block the progression of preneoplastic lesions to full blown prostate (Chen et al., 2005; Majumder et al., 2008), colon (Bartkova et al., 2006; Kuilman et al., 2008; Fujita et al., 2009; Bennecke et al., 2010), lymph (Braig et al., 2005), and breast (Swarbrick et al.,…”
WRN at telomeres: implications for aging and cancer
Multani, A. S., & Chang, S. (2007) · Journal of Cell Science · doi:10.1242/jcs.03397 · Cited by 95
DNA damage checkpoint recovery and cancer development
Wang, H., Zhang, X., Teng, L., & Legerski, R. J. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.03.011 · Cited by 106
Tu, Z., Aird, K. M., Bitler, B. G., Nicodemus, J. P., Beeharry, N., Xia, B., Yen, T. J., & Zhang, R. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.10.010 · Cited by 88
“Oncogene-induced senescence is often characterized by the accumulation of DNA damage; in particular, DNA double-strand breaks (DSBs) (Bartkova et al., 2006; Di Micco et al., 2006).”
InfluentialDNA double-strand break signaling and human disorders
Bohgaki, T., Bohgaki, M., & Hakem, R. (2010) · Genome Integrity · doi:10.1186/2041-9414-1-15 · Cited by 123
Cellular senescence in cancer: clinical detection and prognostic implications
Domen, A., Deben, C., Verswyvel, J., Flieswasser, T., Prenen, H., Peeters, M., Lardon, F., & Wouters, A. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02555-3 · Cited by 94
Cellular Senescence in the Development and Treatment of Cancer
Saretzki, G. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210789941874 · Cited by 87
“p53 acts as a mediator of the DNA damage response by transmitting the signal from structures that sense DNA damage- such as either short telomeres or activated oncogenes- via the ATM and Chk2 DNA damage signaling cascade to downstream effectors that stop cell cycle progression [41].”
BackgroundWnt Antagonist SFRP1 Functions as a Secreted Mediator of Senescence
Elzi, D. J., Song, M., Hakala, K., Weintraub, S. T., & Shiio, Y. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06023-11 · Cited by 89
Pathogenesis of cancers derived from thyroid follicular cells
Fagin, J. A., Krishnamoorthy, G. P., & Landa, I. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00598-y · Cited by 94
Gurvich, N., Perna, F., Farina, A., Voza, F., Menendez, S., Hurwitz, J., & Nimer, S. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017092108 · Cited by 89
Kinjo, T., Ham-Terhune, J., Peloponese, J.-M., & Jeang, K.-T. (2010) · Journal of Virology · doi:10.1128/jvi.02460-09 · Cited by 87
“A frequent physiological reactive response of nontransformed cells to DNA damage is senescence (3, 8, 33).”
BackgroundThe Cytolethal Distending Toxin Effects on Mammalian Cells: A DNA Damage Perspective
Bezine, E., Vignard, J., & Mirey, G. (2014) · Cells · doi:10.3390/cells3020592 · Cited by 103
“DDR downregulation prevents senescence initiation and maintenance, allowing cell proliferation and predisposing cells to oncogenic transformation [107,108].”
BackgroundSewell, A. B., Brown, B. T., Biktasova, A., Mills, G. B., Lu, Y., Tyson, D. R., Issaeva, N., & Yarbrough, W. G. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2585 · Cited by 101
“unscheduled S-phase entry, which can result in DNA damage, including double-strand breaks at stalled replication forks (32).”
Self-citationYin, S., Gambe, R. G., Sun, J., Martinez, A. Z., Cartun, Z. J., Regis, F. F., Wan, Y., Fan, J., Brooks, A. N., Herman, S. E. M., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2018.12.013 · Cited by 97
Cipriano, R., Kan, C. E., Graham, J., Danielpour, D., Stampfer, M., & Jackson, M. W. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015022108 · Cited by 92
The Senescence–Stemness Alliance – A Cancer-Hijacked Regeneration Principle
Milanovic, M., Yu, Y., & Schmitt, C. A. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.09.001 · Cited by 92
Cannell, I. G., Merrick, K. A., Morandell, S., Zhu, C., Braun, C. J., Grant, R. A., Cameron, E. R., Tsao, M., Hemann, M. T., & Yaffe, M. B. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.09.009 · Cited by 95
“During tumor evolution, however, many, if not all tumors disrupt components of the DNA damage response network (DDR) to escape oncogene-induced senescence (Bartkova et al., 2006), ultimately contributing to genomic instability.”
BackgroundShen, W., Liu, L., & Zeng, S. (2018) · Cancer translational medicine · doi:10.4103/ctm.ctm_22_18 · Cited by 98
The Emerging Role of Cyclin-Dependent Kinases (CDKs) in Pancreatic Ductal Adenocarcinoma
García-Reyes, B., Kretz, A.-L., Ruff, J.-P., von Karstedt, S., Hillenbrand, A., Knippschild, U., Henne‐Bruns, D., & Lemke, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103219 · Cited by 102
Blanco, D., Vicent, S., Fraga, M. F., Fernandez-Garcia, I., Freire, J., Lujambio, A., Esteller, M., Ortiz-de-Solorzano, C., Pio, R., Lecanda, F., et al. (2007) · Neoplasia · doi:10.1593/neo.07517 · Cited by 92
Liu, C., Srihari, S., Cao, K. L., Chenevix‐Trench, G., Simpson, P. T., Ragan, M. A., & Khanna, K. K. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku284 · Cited by 107
Conventional chemotherapy: millions of cures, unresolved therapeutic index
Letai, A. G., & de Thé, H. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00778-4 · Cited by 123
“Such oncogene-associated DDR initiates senescence, which in this case serves as an initial fail-safe mechanism to block further transformation 47 .”
Chuang, C.-H., Wallace, M. D., Abratte, C. M., Southard, T. L., & Schimenti, J. C. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001110 · Cited by 91
“Our data contribute to a growing body of data that replication stress, which can occur via perturbations of the DNA replication machinery, plays a significant role in driving cancer [38–41].”
BackgroundFrom cancer immunosurveillance to cancer immunotherapy
Stagg, J., Johnstone, R. W., & Smyth, M. J. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00566.x · Cited by 107
“(21) demonstrated that oncogene-induced senescence does not require p16 but instead causes unbalanced DNA replication that triggers a classical DNAdamage response culminating in cellular senescence.”
BackgroundCellular Senescence: The Trojan Horse in Chronic Lung Diseases
Hamsanathan, S., Alder, J. K., Sellares, J., Rojas, M., Gurkar, A. U., & Mora, A. L. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0410tr · Cited by 86
MYC and the Control of DNA Replication
Dominguez-Sola, D., & Gautier, J. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014423 · Cited by 85
Zhao, M., Chen, L., & Qu, H. (2016) · Cell Death & Disease · doi:10.1038/cddis.2015.414 · Cited by 86
Santoriello, C., Deflorian, G., Pezzimenti, F., Kawakami, K., Lanfrancone, L., d’Adda di Fagagna, F., & Mione, M. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.001016 · Cited by 87
A role for AID in chromosome translocations between c-myc and the IgH variable region
Dorsett, Y., Robbiani, D. F., Janković, M., Reina‐San‐Martin, B., Eisenreich, T., & Nussenzweig, M. C. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070884 · Cited by 110
Type I interferons and related pathways in cell senescence
Frisch, S. M., & MacFawn, I. P. (2020) · Aging Cell · doi:10.1111/acel.13234 · Cited by 85
“This response is thought to represent a specialized form of DNA damage signaling arising from replicative stress in response to mitogenic overstimulation (Bartkova et al., 2006; Di Micco et al., 2006).”
BackgroundGenetic and epigenetic dependencies in colorectal cancer development
Parmar, S., & Easwaran, H. (2022) · Gastroenterology report · doi:10.1093/gastro/goac035 · Cited by 99
TORC2 Signaling Pathway Guarantees Genome Stability in the Face of DNA Strand Breaks
Shimada, K., Filipuzzi, I., Ståhl, M., Helliwell, S. B., Studer, C., Hoepfner, D., Seeber, A., Loewith, R., Movva, N. R., & Gasser, S. M. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.08.019 · Cited by 94
“Intriguingly, oncogene activation itself triggers replication fork-associated stress and activates a low-level Molecu checkpoint response (Bartkova et al., 2006; Di Micco et al., 2006).”
Senescence and immortality in hepatocellular carcinoma
Öztürk, M., Arslan-Ergül, A., Baǧışlar, S., Şentürk, Ş., & Yuzugullu, H. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.10.048 · Cited by 105
Tiram, G., Segal, E., Krivitsky, A., Shreberk-Hassidim, R., Ferber, S., Ofek, P., Udagawa, T., Edry, L., Shomron, N., Roniger, M., et al. (2016) · ACS Nano · doi:10.1021/acsnano.5b06189 · Cited by 86
Molecular damage in cancer: an argument for mTOR-driven aging
Blagosklonny, M. V. (2011) · Aging · doi:10.18632/aging.100422 · Cited by 90
“In oncogene-induced senescence (OIS), DDR causes cell cycle arrest, leading to senescence [238-245].”
BackgroundThe DNA damage checkpoint response to replication stress: A Game of Forks
Jossen, R., & Bermejo, R. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00026 · Cited by 110
“…proliferating cells, show constitutively activated checkpoint kinases and markers of DNA breakage (Bartkova et al., 2005; Gorgoulis et al., 2005) and that oncogene activation induces replication stress, fork collapse, and formation of DNA breaks (Bartkova et al., 2006; Di Micco et al., 2006).”
BackgroundKrebs cycle: activators, inhibitors and their roles in the modulation of carcinogenesis
Gasmi, A., Peana, M., Arshad, M., Butnariu, M., Menzel, A., & Bjørklund, G. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-02974-9 · Cited by 96
Chemokines in triple-negative breast cancer heterogeneity: New challenges for clinical implications
Mehraj, U., Mushtaq, U., Mir, M. A., Saleem, A., Macha, M. A., Lone, M. N., Hamid, A., Zargar, M. A., Ahmad, S. M., & Wani, N. A. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.008 · Cited by 93
Oncogene activation in melanocytes links reactive oxygen to multinucleated phenotype and senescence
Leikam, C., Hufnagel, A., Schartl, M., & Meierjohann, S. (2008) · Oncogene · doi:10.1038/onc.2008.323 · Cited by 96
Two sides of the Myc-induced DNA damage response: from tumor suppression to tumor maintenance
Campaner, S., & Amati, B. B. (2012) · Cell Division · doi:10.1186/1747-1028-7-6 · Cited by 94
Is DNA damage indispensable for stress-induced senescence?
Bielak-Żmijewska, A., Mosieniak, G., & Sikora, E. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.08.004 · Cited by 93
Androgen Depletion Induces Senescence in Prostate Cancer Cells through Down-regulation of Skp2
Pernicová, Z., Slabáková, E., Kharaishvili, G., Bouchal, J., Král, M., Kunická, Z., Machala, M., Kozubík, A., & Souček, K. (2011) · Neoplasia · doi:10.1593/neo.11182 · Cited by 92
Implications of Oxidative Stress and Cellular Senescence in Age-Related Thymus Involution
Barbouti, A., Vasileiou, P. V. S., Evangelou, K., Vlasis, K. G., Papoudou‐Bai, A., Gorgoulis, V. G., & Kanavaros, P. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/7986071 · Cited by 91
Self-citationIs cellular senescence an example of antagonistic pleiotropy?
Giaimo, S., & d’Adda di Fagagna, F. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00807.x · Cited by 77
The complex basis underlying common fragile site instability in cancer
Ozeri-Galai, E., Bester, A. C., & Kerem, B. (2012) · Trends in Genetics · doi:10.1016/j.tig.2012.02.006 · Cited by 97
Tumor suppression by p53: making cells senescent.
Qian, Y., & Chen, X. (2010) · PubMed · doi:10.14670/hh-25.515 · Cited by 85
“It has been reported that OIS is accompanied by DNA replicative stress, including prematurely terminated DNA replication forks and DNA double-strand breaks caused by hyper-DNA replication (Bartkova et al., 2006; Di Micco et al., 2006).”
RAD51 as a potential biomarker and therapeutic target for pancreatic cancer
Nagathihalli, N. S., & Nagaraju, G. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.07.004 · Cited by 95
p38α and p38γ Mediate Oncogenic ras-induced Senescence through Differential Mechanisms
Kwong, J., Hong, L., Liao, R., Deng, Q., Han, J., & Sun, P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808327200 · Cited by 82
Human Xip1 (C2orf13) Is a Novel Regulator of Cellular Responses to DNA Strand Breaks
Bekker-Jensen, S., Fugger, K., Rendtlew Danielsen, J., Gromova, I., Sehested, M., Celis, J., Bartek, J., Lukas, J., & Mailand, N. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.c700060200 · Cited by 82
Self-citationMannava, S., Moparthy, K. C., Wheeler, L. J., Natarajan, V., Zucker, S. N., Fink, E. E., Im, M., Flanagan, S., Burhans, W. C., Zeitouni, N. C., et al. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.09.011 · Cited by 82
“However, this is an unlikely scenario since inhibition of DDR proteins ATM or CHK2 abolishes HRAS G12V -induced senescence in NHF presumably via dNTP-independent mechanism (4-7).”
BackgroundYu, H., McDaid, R., Lee, J., Possik, P. A., Li, L., Kumar, S. M., Elder, D. E., Belle, P. A. V., Gimotty, P. A., Guerra, M., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081057 · Cited by 94
Crosstalk between the Rb pathway and AKT signaling forms a quiescence-senescence switch.
Imai, Y., Takahashi, A., Hanyu, A., Hori, S., Sato, S., Naka, K., Hirao, A., Ohtani, N., & Hara, E. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.006 · Cited by 84
Pathways for maintenance of telomeres and common fragile sites during DNA replication stress
Özer, Ö., & Hickson, I. D. (2018) · Open Biology · doi:10.1098/rsob.180018 · Cited by 91
The controversial role of senescence-associated secretory phenotype (SASP) in cancer therapy
Cao, L., Li, K., Li, Q., Tong, Q., Wang, Y., & Huang, L. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02475-8 · Cited by 93
“The DDR [79], p53/ p21 [8], p16/Rb [119], and MAPK [120, 121] pathways are among the several signaling pathways involved in OIS, a strong and long-lasting antiproliferative response.”
Miles, S., Li, L., Davison, J., & Breeden, L. L. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003854 · Cited by 91
“Related effects have been observed with excess cyclin E, and other activated oncogenes in higher cells [50,51] and in yeast [26,27,52].”
BackgroundMcCabe, N., Hanna, C., Walker, S. M., Gonda, D., Li, J., Wikstrom, K., Savage, K. I., Butterworth, K. T., Chen, C., Harkin, D. P., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3502 · Cited by 79
Camps, J., Grade, M., Nguyen, Q. T., Hörmann, P., Becker, S., Hummon, A. B., Rodriguez, V., Chandrasekharappa, S. C., Chen, Y., Difilippantonio, M. J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2864 · Cited by 90
“Oncogeneinduced senescence has recently been shown to induce a DNA damage response in tissue culture models (41, 42 ) as well as in vivo during the development of thymocytes (43), and is able to restrict the growth of human and murine precancerous tissues (44–48).”
BackgroundStudies of genomic copy number changes in human cancers reveal signatures of DNA replication stress
Dereli‐Öz, A., Versini, G., & Halazonetis, T. D. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2011.05.002 · Cited by 95
Self-citationConsequences of Lamin B1 and Lamin B Receptor Downregulation in Senescence
Lukášová, E., Kovařík, A., & Kozubek, S. (2018) · Cells · doi:10.3390/cells7020011 · Cited by 101
“Upregulation of p16INK4a is particularly prevalent in benign lesions, although is often lost upon malignancy [31], and its expression can be dispensable in senescence [32,33].”
Background
Metadata
- Authors
- Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., Takaoka, M., Nakagawa, H., Tort, F., Fugger, K., Johansson, F., Sehested, M., Andersen, C. L., Dyrskjot, L., Ørntoft, T., Lukas, J., Kittas, C., Helleday, T., Halazonetis, T. D., Bartek, J., & Gorgoulis, V. G.
- Affiliations
- The Wistar Institute (US)
- National and Kapodistrian University of Athens (GR)
- National Centre of Scientific Research "Demokritos" (GR)
- Stockholm University (SE)
- University of Ioannina (GR)
- National Hellenic Research Foundation (GR)
- University of Pennsylvania (US)
- Danish Cancer Society (DK)
- Copenhagen University Hospital (DK)
- Aarhus University Hospital (DK)
- Corresponding author
- Halazonetis, Thanos D.
- ORCID
- Venue
- Nature
- Published
- 2006-11
- Volume
- 444
- Issue
- 7119
- Pages
- 633-637
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2041156660
- Cited by
- 1,986
- References
- 30
- Citations by year
- 2026: 35 · 2025: 74 · 2024: 65 · 2023: 92 · 2022: 74 · 2021: 96 · 2020: 88 · 2019: 83 · 2018: 108 · 2017: 100 · 2016: 122 · 2015: 88 · 2014: 134 · 2013: 129 · 2012: 132
- FWCI
- 65.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- National Hellenic Research Foundation Helios Repository (National Hellenic Research Foundation) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- oncogene-induced senescence, DNA damage response, replication stress, DNA double-strand breaks, ATM kinase, precancerous lesions, senescence markers, tumor progression, apoptosis
- MeSH terms
- Animals, Cell Line, Cell Transformation, Neoplastic, DNA, DNA Damage, DNA Replication, Humans, Neoplasm Invasiveness, Nuclear Proteins, Oncogenes, Precancerous Conditions, Genes, mos, Cellular Senescence, Cell Cycle Proteins, Cyclin E, Cyclin-Dependent Kinase Inhibitor p16, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.